Kunlun Pharmaceutical Group: Planning to use 2.5 billion yuan of idle proprietary funds for investment and financial management.

Kunyao Group Announcement: The company plans to use no more than 2.5 billion RMB of idle funds for investment and financial management. The investment will be in medium to low-risk, high-return financial products. This matter has been reviewed and approved by the board of directors and the supervisory board, and still needs to be submitted for approval at the shareholders' meeting. The investment period is within 1 year from the date of approval at the shareholders' meeting, and the funds can be used repeatedly. The company's financial and operational management center will evaluate the risks, investment direction, and returns of financial products strictly in accordance with the Kunyao Group Limited Cash Management System, and establish ledgers, strengthen regular tracking and management, and strictly control risks.